Abstract
Advances in the development of innovative medical devices and telehealth technologies create the potential to improve the quality and efficiency of diabetes care through collecting, aggregating, and interpreting relevant health data in ways that facilitate more informed decisions among all stakeholder groups. Although many medical societies publish guidelines for utilizing these technologies in clinical practice, we believe that the methodologies used for the selection and grading of the evidence should be revised. In this article, we discuss the strengths and limitations of the various types of research commonly used for evidence selection and grading and present recommendations for modifying the process to more effectively address the rapid pace of device and technology innovation and new product development.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1698-1710 |
| Number of pages | 13 |
| Journal | Journal of Diabetes Science and Technology |
| Volume | 17 |
| Issue number | 6 |
| DOIs |
|
| State | Published - Nov 2023 |
Keywords
- CGM
- continuous glucose monitoring
- diabetes technologies
- guidelines
- randomized controlled trials
- real-world evidence
ASJC Scopus subject areas
- Internal Medicine
- Endocrinology, Diabetes and Metabolism
- Bioengineering
- Biomedical Engineering
Fingerprint
Dive into the research topics of 'Guideline Development for Medical Device Technology: Issues for Consideration'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS